Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / OVID - Ovid Therapeutics names Jason Tardio Chief Operating Officer

OVID - Ovid Therapeutics names Jason Tardio Chief Operating Officer

Ovid Therapeutics Inc.
Ovid Therapeutics (OVID) announced the appointment of life sciences industry veteran Jason Tardio as the company's Chief Operating Officer, and made slew of leadership changes.Tardio has over 20 years of leadership experience in the life sciences industry and joined Ovid in 2019 as the company’s Chief Commercial Officer. The company also made other leadership appointments: named Claude Nicaise Head of Research and Development; Added neurologist Michael Poole to its board of directors; Amit Rakhit will join the Ovid's Scientific and Clinical Advisory Board, when he leaves from his full time role at the end of August.

For further details see:

Ovid Therapeutics names Jason Tardio Chief Operating Officer
Stock Information
Company Name: Ovid Therapeutics Inc.
Stock Symbol: OVID
Market: NASDAQ
Website: ovidrx.com
Menu
OVID OVID Quote OVID Short OVID News OVID Articles OVID Message Board
Get OVID Alerts

News, Short Squeeze, Breakout and More Instantly...